Mousmee Sharma – författare

This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.

This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.

This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.

The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.

Key Features:

The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.

This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.

The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.

Key Features:

The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.

The book explores the intersection of nanotechnology and allergic airway diseases. With a focus on diagnosis and management, each chapter delves into specific areas of interest. Beginning with an introduction to the diseases, the book progresses to uncover the pathophysiology and immunology underlying allergic airway diseases. The epidemiology chapter provides insights into the prevalence and impact of these conditions. A significant portion of the book is dedicated to nanotechnology applications, with chapters on metal and metal oxide nanoparticles, nanomicelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots. These chapters delve into the potential of these nanomaterials in managing allergic airway diseases, highlighting their unique properties, and promising therapeutic approaches. Finally, the book concludes with a chapter on future directions, exploring emerging trends and potential advancements in the field. This book will be a valuable resource for academics, caregivers, researchers, and industry professionals working in the field of airway allergic diseases. It includes translational and clinical researchers, under-graduates and postgraduates (Masters), PhDs, and post-doctoral researchers of various disciplines, including pharmaceutical sciences, biotechnology, immunology, and medical and health sciences.